Biomedical subjects
A J Ryan
Publications and source records attributed to A J Ryan.
Will you ... won't you join the dance?
Explore the source record for details and available documents.
Can medically related costs be cut?
Explore the source record for details and available documents.
All the world's a stage.
Explore the source record for details and available documents.
Introduction. Dermatology: a group of three related articles.
Explore the source record for details and available documents.
Sports medicine today.
Explore the source record for details and available documents.
Pharmacokinetics of aryldihydro-s-triazines with antifolate activity I: metabolism and excretion by rats.
Explore the source record for details and available documents.
Pharmacokinetics of Aryldihydro-s-triazines with antifolate activity II: Blood levels and their relevance to antineoplastic activity in rats.
Blood levels of three aryldihydro-s-triazines in rats were followed: 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-phenyl-s-triazine (I), the prototype of the series; 4,6-diamino-1-(3,4-dichlorophenyl)-1,2-dihydro-2,2-dimethyl-s-triazine (II); and N-(m-tolyl)-p-(4,6-diamino-1,2-dihydro-2,2-dimethyl-s-triazin-1-yl)hydrocinnamide (III). The blood profiles obtained provide substantial evidence that III, but not II, was precipitated in the peritoneal cavity where it was injected. Precipitation after intraperitoneal injection may explain why III and similar triazines with long nonpolar chains have been reported to be more active against intraperitoneal Walker 256 tumor than is II, even though the latter compound is a far more potent inhibitor of Walker 256 dihydrofolate reductase and of tumor cell cultures in vitro. Precipitation in the peritoneal cavity also may be involved in the difficulty of obtaining the toxicity-free antineoplastic activity expected from certain aryldihydrotriazines selectively inhibiting neoplastic dihydrofolate reductase.
The recombinant bogeyman.
Explore the source record for details and available documents.
The drug regulation reform act of 1978.
Explore the source record for details and available documents.
Are physicians giving away their profession?
Explore the source record for details and available documents.
OTCs and PPIs what is going on here?
Explore the source record for details and available documents.
Peptic ulcer disease: introduction.
Explore the source record for details and available documents.
Generics: is there a choice?
Explore the source record for details and available documents.
Opening guns: strategy behind Carter salvo against the AMA.
Explore the source record for details and available documents.
Is there intelligent life at DHEW?
Explore the source record for details and available documents.